Eli Lilly and Co
XBER:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XBER:LLY
|
US |
|
C
|
Capital One Financial Corp
XBER:CFX
|
US |
|
A
|
ANSYS Inc
SWB:AKX
|
US |
|
H
|
Henry Schein Inc
LSE:0L3C
|
US |
Wall St Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for LLY is 1 125.88 EUR with a low forecast of 793.07 EUR and a high forecast of 1 454.96 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LLY's stock price target?
Price Target
1 125.88
EUR
According to Wall Street analysts, the average 1-year price target for LLY is 1 125.88 EUR with a low forecast of 793.07 EUR and a high forecast of 1 454.96 EUR.
What is the Revenue forecast for Eli Lilly and Co?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for Eli Lilly and Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Eli Lilly and Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 17%.
